Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**THEMIS MEDICARE LIMITED – FINANCIAL RISK SUMMARY** Themis Medicare faces critical compliance exposure: a perfect 10.0/10 compliance risk score combined with unknown EPR (Extended Producer Responsibility) applicability creates regulatory uncertainty that could trigger SEBI enforcement action or disclosure penalties under BRSR Core Expansion mandates. The company's failure to report Scope 1 and 2 emissions despite being a manufacturing-intensive pharma player suggests either data gaps or non-compliance with mandatory GHG accounting requirements, representing potential fines and reputational damage. EPR exposure at 6.5/10 is material for a pharmaceutical formulations manufacturer—estimated compliance costs remain undefined, but sector peers typically face ₹10–50 lakh annual EPR liabilities; without clarification, unquantified liability sits on the balance sheet. Immediate priority: formal emissions quantification and EPR status determination to avoid regulatory action and restore stakeholder confidence.
Source: THEMIS MEDICARE LIMITED BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.